Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00878228 · ClinicalTrials.gov registry record · Phase 4
Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy
A Phase 4 study of Nausea and Vomiting, Postoperative, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT00878228: Completed Phase 4 study of Nausea and Vomiting, Postoperative, sponsored by Hospital for Special Surgery, New York.
NCT00878228 is a Phase 4 study of Nausea and Vomiting, Postoperative that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 98 participants, below the 248-participant average among 5 other Nausea and Vomiting, Postoperative trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00878228, a Phase 4 study of Nausea and Vomiting, Postoperative, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a randomized placebo controlled trial to determine whether repeated postoperative prophylactic ondansetron ("Zofran") administration will prevent postoperative and/or postdischarge nausea and vomiting in patients undergoing ambulatory hip arthroscopy. Ondansetron will be administered in the intra- and post-operative period. These individuals will be followed on postoperative days 1, 2, and 3. It is hypothesized that the incidence of postdischarge nausea and vomiting (PDNV) will be significantly decreased by postoperative prophylactic administration of multiple doses of ondansetron (Zofran).
Primary Outcome
Percentage of participants with nausea
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ondansetron
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
What the finished NCT00878228 record still lists
NCT00878228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 248-participant average among 5 other Nausea and Vomiting, Postoperative trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Nausea and Vomiting, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00878228 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00878228 about?
NCT00878228 is a clinical study titled "Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy". The study is a randomized placebo controlled trial to determine whether repeated postoperative prophylactic ondansetron ("Zofran") administration will prevent postoperative and/or postdischarge nausea and vomiting in patients undergoing ambulatory hip arthroscopy. Ondansetron will be administered in...
What is the current status of trial NCT00878228?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2009-04. Estimated completion is 2010-02.
What conditions does trial NCT00878228 study?
This clinical trial studies the following conditions: Nausea and Vomiting, Postoperative.
What interventions are being tested in trial NCT00878228?
The interventions under investigation include: Placebo (DRUG), Ondansetron (DRUG).
Who is sponsoring clinical trial NCT00878228?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00878228 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nausea and Vomiting, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dexamethasone vs Ondansetron After Cesarean Delivery
COMPLETED · Phase 4
-
ENDOblock: Bilateral Superficial Cervical Blocks With Local Wound Infiltration in Thyroid Surgery
ACTIVE NOT RECRUITING · NA
-
Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks
ACTIVE NOT RECRUITING · Phase 1
-
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
COMPLETED · Phase 3
-
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia